Sio Gene Therapies Inc (SIOX) Annual Balance Sheets

Annual · GAAP · USD millions
Access SIOX quarterly Balance Sheets →
Examining balance sheet movements between Sio Gene Therapies Inc and Mar 31 2018 reveals how Mar 31 2022 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Mar 31 2022)
(Mar 31 2021) (Mar 31 2020) (Mar 31 2019) (Mar 31 2018)
Assets
Cash & cash equivalent63.73
Cash & Short-term Investments63.00
Income Taxes Receivable, Current NO1.61
Other Current Assets1.18
Prepaid Expense And Other Assets Current5.21
Total Current Assets71.74
Equipment/Property/Plant Net0.90
Other Assets, Noncurrent0.00
Receivable From Sale Of Long Term Investment0.00
Operating Lease Right Of Use Asset2.44
Total Assets75.08
Liabilities
Accounts Payable, Current AC3.98
Accrued Liabilities, Current AC8.23
Short-term Debt0.00
Other Liabilities, Current0.79
Total Current Liabilities13.00
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent1.73
Operating Lease Liability Current0.79
Operating Lease Liability Noncurrent1.73
Total Liabilities14.73
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock922.97
Retained Earnings / Accumulated Deficit-862.96
Other Equity0.34
Common Stockholder's Equity60.35
Total Stockholder's Equity60.35
Liabilities & Stockholder's Equity75.08
4 historic quarters locked

Sign in to unlock the full Sio Gene Therapies Inc balance sheet history.

About Sio Gene Therapies Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001636050-23-000007

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License